Novacea
Latest round
- Series C
Last raised
- Jan 2006
Total raised
- $60M
Investors
- 6
About Novacea
Novacea, Inc. is a US-based biopharmaceutical company focused on developing innovative treatments for cancer.Novacea, Inc. specializes in biopharmaceuticals targeting cancer therapies. The company was founded in San Francisco, US.5 each.Novacea, Inc. focuses on developing drug therapies for cancer, employing cutting-edge research and clinical trials to advance its product offerings. The company is targeting the launch of new products aimed at specific cancer types by 2025, while also exploring expansion into international markets, particularly in Europe and Asia, to broaden its reach and impact.
Who invested in Novacea
6 investors across 2 rounds
See all investors in Novacea
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Novacea
Who invested in Novacea?
Novacea has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Novacea raised?
Novacea has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Novacea last raise money?
Novacea's most recent round on record is a Series C, in Jan 2006.
What does Novacea do?
Novacea is a healthcare specialists company.
Where is Novacea headquartered?
Novacea is headquartered in San Francisco, US.
Which VCs invest in companies like Novacea?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare specialists companies at Novacea's stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Series C
Raising like Novacea? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.